NCT06809816View on ClinicalTrials.gov

Efficacy of OsteoBor in Postmenopausal Osteoporosis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

September 1, 2025

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

Sodium pentaborate pentahydrate

Sodium pentaborate pentahydrate will be administered orally in capsule form, following the standard protocol outlined in the study design.

All Listed Sponsors
lead

Tabriz University of Medical Sciences

OTHER